Literature DB >> 8613352

Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.

J B Dale1, R G Washburn, M B Marques, M R Wessels.   

Abstract

The major virulence determinant of group A streptococci is the ability to resist opsonization and phagocytic ingestion. The present studies were performed to compare the mechanisms of resistance to opsonization of type 18 and type 24 streptococci and to determine the relative roles of M protein-fibrinogen interaction and the hyaluronate capsule in preventing phagocytic ingestion and killing. By use of parent strains and acapsular transposon mutants in the presence and absence of fibrinogen, we show that type 18 and type 24 streptococci rely on somewhat different mechanisms for resistance to opsonization. Type 24 streptococci bound fibrinogen avidly to their surfaces, and encapsulated organisms were completely resistant to opsonization only in the presence of fibrinogen. In contrast, type 18 streptococci bound 10-fold less fibrinogen than type 24 streptococci and were fully resistant to phagocytosis only when they expressed capsule. The general structural characteristics of the amino-terminal halves of type 18 and type 24 M proteins differed in that type 18 M protein contained only one complete B repeat, whereas type 24 M protein contained five complete B repeats, a structural difference which could potentially be related to the differences in fibrinogen binding between the two serotypes. Immunofluorescence assays of complement deposition were used in combination with 125I-C3 binding assays to show that encapsulated type 24 streptococci were fully resistant to opsonization by C3 only in the presence of plasma. Encapsulated and unencapsulated type 18 streptococci were equally opsonized by C3 in either plasma or serum, yet only encapsulated organisms resisted phagocytic killing in blood. The results of this study indicate that opsonization by C3 does not necessarily lead to phagocytic ingestion and that the hyaluronate capsule and M proteins are variably important in resistance to different group A streptococci to opsonization and phagocytic killing.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613352      PMCID: PMC173953          DOI: 10.1128/iai.64.5.1495-1501.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Molecular evolution of streptococcal M protein: cloning and nucleotide sequence of the type 24 M protein gene and relation to other genes of Streptococcus pyogenes.

Authors:  A R Mouw; E H Beachey; V Burdett
Journal:  J Bacteriol       Date:  1988-02       Impact factor: 3.490

2.  Biochemical and biological properties of the binding of human fibrinogen to M protein in group A streptococci.

Authors:  E Whitnack; E H Beachey
Journal:  J Bacteriol       Date:  1985-10       Impact factor: 3.490

3.  Comparison of the leader sequences of four group A streptococcal M protein genes.

Authors:  E Haanes-Fritz; W Kraus; V Burdett; J B Dale; E H Beachey; P Cleary
Journal:  Nucleic Acids Res       Date:  1988-05-25       Impact factor: 16.971

4.  Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.

Authors:  R D Horstmann; H J Sievertsen; J Knobloch; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface.

Authors:  G N Phillips; P F Flicker; C Cohen; B N Manjula; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

6.  Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci.

Authors:  E Whitnack; E H Beachey
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

7.  Human fibrinogen specifically binds hyaluronic acid.

Authors:  R D LeBoeuf; R H Raja; G M Fuller; P H Weigel
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

8.  Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages.

Authors:  E Whitnack; A L Bisno; E H Beachey
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

9.  Size variation of the M protein in group A streptococci.

Authors:  V A Fischetti; K F Jones; J R Scott
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

10.  Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein.

Authors:  J B Dale; J M Seyer; E H Beachey
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more
  64 in total

1.  New protective antigen of group A streptococci.

Authors:  J B Dale; E Y Chiang; S Liu; H S Courtney; D L Hasty
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB.

Authors:  Melissa Drysdale; Agathe Bourgogne; Susan G Hilsenbeck; Theresa M Koehler
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

3.  Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64.

Authors:  R Raeder; E Harokopakis; S Hollingshead; M D Boyle
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Genetic characterization and virulence role of the RALP3/LSA locus upstream of the streptolysin s operon in invasive M1T1 Group A Streptococcus.

Authors:  Laura A Kwinn; Arya Khosravi; Ramy K Aziz; Anjuli M Timmer; Kelly S Doran; Malak Kotb; Victor Nizet
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

Review 5.  Engineering antiphagocytic biomimetic drug carriers.

Authors:  Alicia Sawdon; Ching-An Peng
Journal:  Ther Deliv       Date:  2013-07

6.  Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection.

Authors:  H M Schrager; J G Rheinwald; M R Wessels
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

7.  Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci.

Authors:  E A Ahmed; T A Penfound; S C Brewer; P A Tennant; E Y Chiang; J B Dale
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-10-29       Impact factor: 3.267

8.  Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs.

Authors:  S Lukomski; E H Burns; P R Wyde; A Podbielski; J Rurangirwa; D K Moore-Poveda; J M Musser
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

9.  Conversion of M serotype 24 of Streptococcus pyogenes to M serotypes 5 and 18: effect on resistance to phagocytosis and adhesion to host cells.

Authors:  H S Courtney; S Liu; J B Dale; D L Hasty
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

10.  To be capsulated or not be capsulated: that is the GAS question.

Authors:  Roberta Creti; Giovanni Gherardi; Monica Imperi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-13       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.